BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 17601681)

  • 1. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
    Massimino M; Gandola L; Collini P; Seregni E; Marchianò A; Serra A; Pignoli E; Spreafico F; Pallotti F; Terenziani M; Biassoni V; Bombardieri E; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):404-10. PubMed ID: 17601681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor.
    Schmiegelow M; Feldt-Rasmussen U; Rasmussen AK; Poulsen HS; Müller J
    J Clin Endocrinol Metab; 2003 Jan; 88(1):136-40. PubMed ID: 12519842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSH suppression as a possible means of protection against hypothyroidism after irradiation for childhood Hodgkins lymphoma.
    Massimino M; Gandola L; Pignoli E; Seregni E; Marchianò A; Pecori E; Catania S; Cefalo G
    Pediatr Blood Cancer; 2011 Jul; 57(1):166-8. PubMed ID: 21557462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.
    Laughton SJ; Merchant TE; Sklar CA; Kun LE; Fouladi M; Broniscer A; Morris EB; Sanders RP; Krasin MJ; Shelso J; Xiong Z; Wallace D; Gajjar A
    J Clin Oncol; 2008 Mar; 26(7):1112-8. PubMed ID: 18309946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the "Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence" (RiSK).
    Bölling T; Geisenheiser A; Pape H; Martini C; Rübe C; Timmermann B; Fischedick K; Kortmann RD; Gerss J; Koch R; Willich N
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e787-91. PubMed ID: 21167655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of suppressing thyroid-stimulating hormone during radiotherapy to prevent primary hypothyroidism in medulloblastoma/PNET and Hodgkin lymphoma: a prospective cohort study.
    Massimino M; Podda M; Gandola L; Pignoli E; Seregni E; Morosi C; Spreafico F; Ferrari A; Pecori E; Terenziani M
    Front Med; 2021 Feb; 15(1):101-107. PubMed ID: 32794013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
    J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid function from birth to adolescence in Prader-Willi syndrome.
    Sharkia M; Michaud S; Berthier MT; Giguère Y; Stewart L; Deladoëy J; Deal C; Van Vliet G; Chanoine JP
    J Pediatr; 2013 Sep; 163(3):800-5. PubMed ID: 23623517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron deficiency anaemia in childhood and thyroid function.
    Tienboon P; Unachak K
    Asia Pac J Clin Nutr; 2003; 12(2):198-202. PubMed ID: 12810411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
    Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vertebral body growth after craniospinal irradiation.
    Hartley KA; Li C; Laningham FH; Krasin MJ; Xiong X; Merchant TE
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1343-9. PubMed ID: 18164830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
    Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
    Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of central hypothyroidism in children on continuous ambulatory peritoneal dialysis.
    Düsünsel R; Poyrazoglu HM; Gündüz Z; Kurtoglu S; Kiris A; Günes T
    Adv Perit Dial; 1999; 15():262-8. PubMed ID: 10682115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors.
    Allen JC; Donahue B; DaRosso R; Nirenberg A
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1155-61. PubMed ID: 8985038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothyroidism in children with medulloblastoma: a comparison of 3600 and 2340 cGy craniospinal radiotherapy.
    Paulino AC
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):543-7. PubMed ID: 12062595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivariate analysis of dissemination relapse of medulloblastoma and estimation of its time parameter for craniospinal irradiation.
    Inakoshi H; Kayamori R; Tsuchida E; Sakai K; Shibamoto Y; Wakushima H; Ogawa Y; Kobayashi M; Obara T
    Radiat Med; 2003; 21(1):37-45. PubMed ID: 12801142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
    Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid dysfunction in HIV-infected children: is L-thyroxine therapy beneficial?
    Rana S; Nunlee-Bland G; Valyasevi R; Iqbal M
    Pediatr AIDS HIV Infect; 1996 Dec; 7(6):424-8. PubMed ID: 11361500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.